Lv51
1288 积分 2024-07-03 加入
The landscape of CAR-engineered innate immune cells for cancer immunotherapy
17天前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
17天前
已完结
Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer
25天前
已完结
Polyethylene glycol immunogenicity in nanomedicine
1个月前
已完结
Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
1个月前
已完结
Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2个月前
已完结
Phagocytic clearance of targeted cells with a synthetic ligand
2个月前
已完结
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
2个月前
已完结
Hybrid micellar preparations for co-delivery of PARP-1 siRNA and quercetin for cataract treatment
3个月前
已完结
皖公网安备34019202002308
